Evaluation Comparison and Standardization of Arthritis Drugs

Evaluation Comparison and Standardization of Arthritis Drugs

EnglishPaperback / softbackPrint on demand
Mittal, Rohit
LAP Lambert Academic Publishing
EAN: 9783843370295
Print on demand
Delivery on Monday, 10. of February 2025
CZK 1,297
Common price CZK 1,441
Discount 10%
pc
Do you want this product today?
Oxford Bookshop Praha Korunní
not available
Librairie Francophone Praha Štěpánská
not available
Oxford Bookshop Ostrava
not available
Oxford Bookshop Olomouc
not available
Oxford Bookshop Plzeň
not available
Oxford Bookshop Brno
not available
Oxford Bookshop Hradec Králové
not available
Oxford Bookshop České Budějovice
not available
Oxford Bookshop Liberec
not available

Detailed information

Arthritis is the inflammation of a joint, which can include infiltration of inflammatory cells, synovial hyperplasia, bone erosion and new bone formation, narrowing of the joint space. Arthritis was induced in knee joint cavity of the right hind leg by intra-articular injection of 0.1ml of 1% carrageenan in all groups except control group. Animals are divided into five different groups such as Normal control, arthritis control, Standard A (MOOV) treated group, Standard B (RUMALAYA) treated group and test drug treated group. Catalase activity, Alkaline Phosphatase, MDA and Uric acid were significantly (p 0.001) altered or comes close to the control group in test drug treated group. Paw volume, Knee diameter and body weight were altered in test drug treated group as compare to reference standard A and B. So we concluded that VPR-011 show significant anti-arthritic activity and better efficacy than other reference standard drugs (MOOV) and (RUMALAYA).
EAN 9783843370295
ISBN 384337029X
Binding Paperback / softback
Publisher LAP Lambert Academic Publishing
Publication date November 28, 2012
Pages 96
Language English
Dimensions 229 x 152 x 6
Readership General
Authors Mittal, Rohit; Patel, Jimish R.; Sharma, Rahul